Balyasny Asset Management LLC Vaxart, Inc. Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.56 - $1.41 $27,428 - $69,061	48,980 New	48,980 $63,000
Q2 2023 Aug 14, 2023	BUY	$0.6 - $1.41 $17,482 - $41,084	29,138 New	29,138 $21,000
Q4 2022 Feb 14, 2023	SELL	$0.75 - $2.24 $24,030 - $71,769	-32,040 Reduced 60.14%	21,235 $20,000
Q3 2022 Nov 14, 2022	BUY	$2.09 - $4.5 $111,344 - $239,737	53,275 New	53,275 $116,000
Q3 2020 Nov 16, 2020	SELL	$4.78 - $16.97 $508,711 - $1.81 Million	-106,425 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$1.68 - $8.85 $178,794 - $941,861	106,425 New	106,425 $942,000

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $73.4M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.